New research from the Michel group could improve drug design Research by the Michel group and Interactive Scientific Limited has created new virtual reality software that could enhance drug design. The technique uses molecular simulation software developed by the Michel group, in conjunction with visualisation using Interactive Scientific Limited's Nano Simbox. Combining the two pieces of software allows researchers to better visualise and understand the complex structures of proteins. This, in turn, could lead to a reduction in the time and money required to bring a new drug to market. More Information Press release on the Interactive Scientific Limited website Publication date 31 Aug, 2018
